ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,321.41
      0.25%
      US Tech 100
      18,234.40
      0.01%
      Dow Jones
      39,872.99
      0.17%
      Brent Oil
      81.705
      -0.90%
      Bitcoin
      70,126.97
      -0.01%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Takeda Pharmaceutical Company Ltd (TAK)

      7. Takeda Pharmaceutical Company Ltd (TAK) Financials

      TAK Takeda Pharmaceutical Company Ltd

      13.20
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:10:58
      Delayed by 15 minutes

      Takeda Pharmaceutical Financial Summary

      The current TAK market cap is 20.89B. The company's latest EPS is JPY 91.0438 and P/E is 0.54.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Total Revenue 962.81B1.06T1.05T1.11T1.06T
      Operating Income 85.67B168.15B-47.32B106.04B-6.33B
      Net Income 31.13B89.4B-48.03B105.72B-3.02B
      Year End March 30 2024 20202021202220232024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Total Revenue 3.35T3.28T3.61T4.05T4.28T
      Operating Income 70.72B275.69B438.73B479.78B220.55B
      Net Income 44.24B376.01B230.06B317.02B144.07B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Total Assets 13.96T14.79T14.87T14.22T15.11T
      Total Liabilities 7.6T7.87T7.8T7.48T7.83T
      Total Equity 6.35T6.92T7.07T6.74T7.27T
      Year End March 30 2024 20202021202220232024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Total Assets 12.82T12.91T13.18T13.96T15.11T
      Total Liabilities 8.09T7.74T7.49T7.6T7.83T
      Total Equity 4.73T5.18T5.68T6.35T7.27T

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Operating 977.16B92.4B291.3B437.76B716.34B
      Investing -607.1B-266.52B-327.11B-402.38B-463.86B
      Financing -709.15B-57.78B-198.43B-296.19B-354.42B
      Year End March 30 2024 20202021202220232024
      JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
      Operating 669.75B1.01T1.12T977.16B716.34B
      Investing 292.12B393.53B-198.13B-607.1B-463.86B
      Financing -1.01T-1.09T-1.07T-709.15B-354.42B

      Stats and Ratios

      Market Cap 20.89B
      Price to Earnings Ratio 0.54
      Price to Sales Ratio 0.02
      Price to Cash Ratio 0.17
      Price to Book Ratio 0.01
      Dividend Yield -

      Share Statistics

      Shares Outstanding 1.58B
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.36 (2.65%)

      Company Info

      Company Name Takeda Pharmaceutical Company Ltd
      Address 4-1-1 doshomachi
      chuo, tokyo 540-8645
      Website https://www.takeda.co.jp
      Industry pharmaceutical diversified (H2)